SCHEMBL3586254

SCHEMBL3586254

COC(=O)c1ccc2c(C3CCCCC3)c(-c3ccccc3CO)n(Cc3ncc[nH]3)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.37
MMP12 P39900 1/20 0.37
SCN9A Q15858 4/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CNR2 P34972 1/20 0.35
CYP3A4 P08684 3/20 0.34
CYP2C19 P33261 3/20 0.34
CYP2C9 P11712 2/20 0.34
DPP4 P27487 1/20 0.34
CYP2D6 P10635 1/20 0.34
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 3/20 0.33
OPRM1 P35372 1/20 0.33
SCARB1 Q8WTV0 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3593873 0.84 CNR2 (0.37) PRKCAMMP12SCN9AHDAC1HDAC8
SCHEMBL3593870 0.82 CNR2 (0.42) PRKCAMMP12HDAC1HDAC8HDAC6
SCHEMBL3584923 0.81 PTGER4 (0.40) PRKCAMMP12SCN9AHDAC1HDAC8
SCHEMBL3586034 0.81 PRKCA (0.38) PRKCAMMP12SCN9AHDAC1HDAC8
SCHEMBL772324 0.77 CNR2 (0.42) PRKCAMMP12SCN9AHDAC1HDAC8
SCHEMBL4826344 0.75 SCN9A (0.41) PRKCAMMP12SCN9AHDAC1HDAC8
Tetrabuthylammonium SCHEMBL4563404 0.75 PTGER4 (0.36) PRKCAMMP12SCN9AHDAC1HDAC8
SCHEMBL4206783 0.74 PRKCA (0.40) PRKCAMMP12SCN9AHDAC1HDAC8
SCHEMBL3092482 0.74 PRKCA (0.40) PRKCAMMP12SCN9AHDAC1HDAC8
SCHEMBL14435483 0.73 PRKCA (0.35) PRKCAMMP12SCN9AHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232390-B2 Pentacyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2012-07-31 US disclosed
US-20100009959-A1 Pentacyclic Indole Derivatives as Antiviral Agents INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-01-14 US disclosed
EP-2027125-A1 PENTACYCLIC INDOLE DERIVATIVES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2009-02-25 EP disclosed
WO-2007129119-A1 PENTACYCLIC INDOLE DERIVATIVES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009959-A1 Pentacyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, ZC3HAV1 PRKCA 2745/4885MMP12 3050/4885SCN9A 4520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.